1. Imaging Biomarkers in Animal Models of Drug-Induced Lung Injury: A Systematic Review
   Irma Mahmutovic Persson et al, 2020, Journal of Clinical Medicine CrossRef
2. Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
   Ayodeji Adegunsoye et al, 2015, Mediators of Inflammation CrossRef
3. Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury
   Tao Liu et al, 2021, Biomaterials CrossRef
4. The active participation of p22phox-214T/C in the formation of intracranial aneurysm and the suppressive potential of edaravone
   Juntao Hu et al, 2018, International Journal of Molecular Medicine CrossRef
5. Edaravone protects against liver fibrosis progression via decreasing the IL-1β secretion of macrophages
   Rongrong Zhao et al, 2022, Chemico-Biological Interactions CrossRef
6. Idiopathic Pulmonary Fibrosis and Antifibrotic Treatments: Focus on Experimental Studies
   Francesca Lunardi et al, 2018, Archives of Pathology & Laboratory Medicine CrossRef
7. Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
   Qilu Wei et al, 2021, Journal of Translational Medicine CrossRef
8. Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics
   Shuchan Li et al, 2022, Cell Biology and Toxicology CrossRef